                         SEQUENCE LISTING

<110>  Colorado State University Research Foundation
       University of Rochester
       McNaughton, Brian R.
       Crawford, David W.
       Wedekind, Joseph E.
 
<120>  ANTI-HIV PEPTIDES

<130>  065620-580726, 581031

<150>  62/418,529
<151>  2016-11-07

<160>  26    

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  1

Leu Asp Ile Leu Val Ser Arg Ser Leu Lys Met Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Thr, Asn, Gln, Lys, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Thr, Asn, Gln, Ser, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Pro, Tyr, Trp, Phe, Leu, Ile, Val, or Ala

<220>
<221>  MISC_FEATURE
<222>  (10)..(13)
<223>  Xaa is any amino acid

<400>  2

Xaa Xaa Pro Arg Xaa Arg Xaa Xaa Arg Xaa Xaa Xaa Xaa 
1               5                   10              


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  X is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Thr, Asn, or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Thr, Asn, Gln, or Ser

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Pro, Tyr, Trp, or Phe

<220>
<221>  MISC_FEATURE
<222>  (10)..(13)
<223>  Xaa is any amino acid

<400>  3

Xaa Xaa Pro Arg Xaa Arg Xaa Xaa Arg Xaa Xaa Xaa Xaa 
1               5                   10              


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(13)
<223>  Xaa is any amino acid

<400>  4

Xaa Xaa Pro Arg Thr Arg Thr Pro Arg Xaa Xaa Xaa Xaa 
1               5                   10              


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Thr, Asn, Gln, Lys, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Thr, Asn, Gln, Ser, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Pro, Tyr, Trp, Phe, Leu, Ile, Val, or Ala

<220>
<221>  MISC_FEATURE
<222>  (13)..(19)
<223>  Xaa is any amino acid

<400>  5

Xaa Xaa Xaa Xaa Xaa Pro Arg Xaa Arg Xaa Xaa Arg Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa 
            


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Thr, Asn, or Gln

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Thr, Asn, Gln, or Ser

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Pro, Tyr, Trp, or Phe

<220>
<221>  MISC_FEATURE
<222>  (13)..(19)
<223>  Xaa is any amino acid

<400>  6

Xaa Xaa Xaa Xaa Xaa Pro Arg Xaa Arg Xaa Xaa Arg Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa 
            


<210>  7
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(19)
<223>  Xaa is any amino acid

<400>  7

Xaa Xaa Xaa Xaa Xaa Pro Arg Thr Arg Thr Pro Arg Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa 
            


<210>  8
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  8

Leu Asp Ile Leu Val Pro Arg His Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  9
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  9

Leu Asp Ile Leu Val Pro Arg Lys Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  10

Leu Asp Ile Leu Val Pro Arg Met Arg Arg Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  11
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  11

Leu Asp Ile Leu Val Pro Arg Met Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  12
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  12

Leu Asp Ile Leu Val Pro Arg Pro Arg Arg Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  13
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  13

Leu Asp Ile Leu Val Pro Arg Pro Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  14
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  14

Leu Asp Ile Leu Val Pro Arg Pro Arg Thr Tyr Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  15
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  15

Leu Asp Ile Leu Val Pro Arg Gln Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  16
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  16

Leu Asp Ile Leu Val Pro Arg Arg Arg Gln Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  17
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  17

Leu Asp Ile Leu Val Pro Arg Arg Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  18
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  18

Leu Asp Ile Leu Val Pro Arg Arg Arg Thr Trp Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  19
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  19

Leu Asp Ile Leu Val Pro Arg Arg Arg Thr Tyr Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  20
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  20

Leu Asp Ile Leu Val Pro Arg Thr Arg Asn Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  21
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  21

Leu Asp Ile Leu Val Pro Arg Thr Arg Arg Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  22
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  22

Leu Asp Ile Leu Val Pro Arg Thr Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  23
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  23

Leu Asp Ile Leu Val Pro Arg Thr Arg Val Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  24
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHESIZED

<400>  24

Leu Asp Ile Leu Val Pro Arg Tyr Arg Thr Pro Arg Gly Gln Ala Phe 
1               5                   10                  15      


Val Ile Phe 
            


<210>  25
<211>  31
<212>  RNA
<213>  Lentivirus Human Immunodeficiency Virus 1

<400>  25
ggccagaucu ggcccuggga ggccucuggc c                                      31


<210>  26
<211>  282
<212>  PRT
<213>  Homo sapiens

<400>  26

Met Ala Val Pro Glu Thr Arg Pro Asn His Thr Ile Tyr Ile Asn Asn 
1               5                   10                  15      


Leu Asn Glu Lys Ile Lys Lys Asp Glu Leu Lys Lys Ser Leu Tyr Ala 
            20                  25                  30          


Ile Phe Ser Gln Phe Gly Gln Ile Leu Asp Ile Leu Val Ser Arg Ser 
        35                  40                  45              


Leu Lys Met Arg Gly Gln Ala Phe Val Ile Phe Lys Glu Val Ser Ser 
    50                  55                  60                  


Ala Thr Asn Ala Leu Arg Ser Met Gln Gly Phe Pro Phe Tyr Asp Lys 
65                  70                  75                  80  


Pro Met Arg Ile Gln Tyr Ala Lys Thr Asp Ser Asp Ile Ile Ala Lys 
                85                  90                  95      


Met Lys Gly Thr Phe Val Glu Arg Asp Arg Lys Arg Glu Lys Arg Lys 
            100                 105                 110         


Pro Lys Ser Gln Glu Thr Pro Ala Thr Lys Lys Ala Val Gln Gly Gly 
        115                 120                 125             


Gly Ala Thr Pro Val Val Gly Ala Val Gln Gly Pro Val Pro Gly Met 
    130                 135                 140                 


Pro Pro Met Thr Gln Ala Pro Arg Ile Met His His Met Pro Gly Gln 
145                 150                 155                 160 


Pro Pro Tyr Met Pro Pro Pro Gly Met Ile Pro Pro Pro Gly Leu Ala 
                165                 170                 175     


Pro Gly Gln Ile Pro Pro Gly Ala Met Pro Pro Gln Gln Leu Met Pro 
            180                 185                 190         


Gly Gln Met Pro Pro Ala Gln Pro Leu Ser Glu Asn Pro Pro Asn His 
        195                 200                 205             


Ile Leu Phe Leu Thr Asn Leu Pro Glu Glu Thr Asn Glu Leu Met Leu 
    210                 215                 220                 


Ser Met Leu Phe Asn Gln Phe Pro Gly Phe Lys Glu Val Arg Leu Val 
225                 230                 235                 240 


Pro Gly Arg His Asp Ile Ala Phe Val Glu Phe Asp Asn Glu Val Gln 
                245                 250                 255     


Ala Gly Ala Ala Arg Asp Ala Leu Gln Gly Phe Lys Ile Thr Gln Asn 
            260                 265                 270         


Asn Ala Met Lys Ile Ser Phe Ala Lys Lys 
        275                 280         


